Table 3.
miRNA | Cancer/Disease Involvement | References |
---|---|---|
miR-15b
miR-16 |
Upregulated in gastric cancer and downregulated in chronic lymphocytic leukemia (CLL) | Xia et al., 2008 [79] Cimmino et al., 2005 [80] Xia et al., 2008 [79] |
LET-7 | Downregulated in lung, pancreatic cancer and acute lymphoblastic leukemia (ALL) | Takamizawa et al., 2004 [81] Kugel et al., 2016 [82] |
miR-34 (a, b and c) | Downregulated in gastric and cervical cancer neuroblastoma. Upregulated in glioblastoma multiforme (GBM) (miR-34b) and colorectal cancer (miR-34a) | Zhang and Liao, 2019 [83] He et al., 2009 [84], Hermeking et al., 2012 [85] Bommer et al., 2007 [86] Tarasov et al., 2007 [87] He et al., 2009 [84] Hasakova et al., 2019 [88] Han et al., 2002 [89] |
miR-21 | Upregulated in GBM, solid tumors and multiple myeloma | Kumarswamy et al., 2011 [90] Asangani et al., 2008 [91] Wang et al., 2019 [92] Jesionek-Kupnicka et al., 2019 [93] Pfeffer et al., 2015 [94] |
miR-125 (a and b) | Upregulated in AML and GBM (miR-125b) | Bousquet et al., 2010 [95] Chaudhuri et al., 2012 [96] Wu et al., 2013 [97] Romero et al., 2015 [98] Liu et al., 2017 [99] Jesionek-Kupnicka et al., 2019 [93] |
miR-181d | Downregulated in GBM | Zhang et al., 2012 [100] Yang et al., 2018 [101] Jesionek-Kupnicka et al., 2019 [93] |
miR-648 | Downregulated in GBM | Kreth et al., 2013 [102] Jesionek-Kupnicka et al., 2019 [93] |
miR-155 | Upregulated in AML, colorectal cancer and Hodgkin’s lymphoma | Fabbri et al., 2008 [103] Narayan et al., 2017 [104] Witten and Slack, 2020 [105] Kluiver et al., 2005 [106] Narayan et al., 2018 [107] Eis et al., 2005 [108] |
miR-221 | Upregulated in GBM | Lukiw et al., 2009 [109] |
miR-30a-5p | Downregulated in colorectal cancer | Wei et al., 2016 [110] |
miR-29 family | Upregulated in colorectal and cervical cancer and downregulated in lung cancer and AML | Fabbri et al., 2007 [44] Jiang et al., 2014 [111] |
miR-145 | Downregulated in colorectal cancer | Michael et al., 2003 [112] Sheng et al., 2017 [113] |
miR-128a | Upregulated in AML | De Luca et al., 2017 [114] |
miR-17/92 cluster | Upregulated and downregulated in myeloid leukemias and upregulated in colorectal cancer and CLL | Fabbri et al., 2008 [103] Jiang et al., 2011 [115] Moussay et al., 2011 [116] Willimott and Wagner, 2012 [117] He et al., 2013 [118] |
miR-7 | Downregulated in GBM | Luo et al., 2015 [119] |
miR-185 | Downregulated in GBM | Zhang et al., 2011 [120] |
miR-24a | Upregulated in AML | Fabbri et al., 2008 [103] |
miR-200 | Downregulated in breast cancer | Mekala et al., 2018 [121] |
miR-150 | Downregulated in CTCL, AML | Jiang et al., 2012 [122] Ito et al., 2014 [123] Abe et al., 2017 [124] |